The Innovation Life Cycle in Health and Medicine and the Challenge of Equity

The Innovation Life Cycle in Health and Medicine and the Challenge of Equity

Any consideration of how the innovation system can be better aligned with equity must begin with an understanding of how technologies in health and medicine develop. This chapter provides an overview of the U.S. system for biomedical science and technology development, using a simplified conceptual model of innovation processes as they take place over time and with the contributions of multiple parties. While no single path of innovation exists, and different technologies follow variable paths of development, this generalized model can assist in identifying how and where inequities arise and how and where technological innovations in health and medicine can be better aligned with equity.

Medigy Insights

The U.S. health-tech innovation process—from idea to market deployment—is shaped by many players (researchers, funders, regulators, insurers) and tends to prioritize speed and profit over equity, meaning underserved communities often lose out.



Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2025 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 14, 2025 at 2:08pm